Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-05-18 Purchase |
2021-05-19 4:15 pm |
Checkmate Pharmaceuticals Inc. | CMPI | Krieg Arthur M Chief Scientific Officer |
25,001 | $6.97 | $174,257 | 1,010,303 (Indirect Direct) |
View |
| 2021-03-29 Purchase |
2021-03-31 8:12 pm |
Checkmate Pharmaceuticals Inc. | CMPI | Krieg Arthur M Chief Scientific Officer |
33,220 | $11.16 | $370,673 | 985,302 (Indirect Direct) |
View |
| 2021-03-25 Purchase |
2021-03-29 4:20 pm |
Checkmate Pharmaceuticals Inc. | CMPI | Krieg Arthur M Chief Scientific Officer |
13,520 | $12.3 | $166,275 | 952,082 (Indirect Direct) |
View |
| 2021-01-27 Purchase |
2021-01-28 4:05 pm |
Checkmate Pharmaceuticals Inc. | CMPI | Krieg Arthur M Chief Scientific Officer |
1,701 | $13.05 | $22,198 | 938,562 (Indirect Direct) |
View |
| 2021-01-19 Purchase |
2021-01-21 5:17 pm |
Checkmate Pharmaceuticals Inc. | CMPI | Krieg Arthur M Chief Scientific Officer |
500 | $13.09 | $6,545 | 936,861 (Indirect Direct) |
View |
| 2020-12-29 Purchase |
2020-12-31 4:20 pm |
Checkmate Pharmaceuticals Inc. | CMPI | Krieg Arthur M Chief Scientific Officer |
443 | $14.16 | $6,273 | 936,361 (Indirect Direct) |
View |
| 2020-12-22 Purchase |
2020-12-23 4:13 pm |
Checkmate Pharmaceuticals Inc. | CMPI | Krieg Arthur M Chief Scientific Officer |
5,103 | $14.64 | $74,708 | 935,918 (Indirect Direct) |
View |
| 2020-12-15 Purchase |
2020-12-17 5:21 pm |
Checkmate Pharmaceuticals Inc. | CMPI | Krieg Arthur M Chief Scientific Officer |
4,847 | $14.62 | $70,858 | 930,815 (Indirect Direct) |
View |
| 2020-08-11 Purchase |
2020-08-13 4:52 pm |
Checkmate Pharmaceuticals Inc. | CMPI | Novo Holdings A/S 10% Owner |
500,000 | $15 | $7,500,000 | 2,170,100 (Direct) |
View |
| 2020-08-11 Purchase |
2020-08-12 9:04 pm |
Checkmate Pharmaceuticals Inc. | CMPI | POWELL MICHAEL Sofinnova Venture Partners IX L.P. Sofinnova Management IX L.L.C. HEALY JAMES Director 10% Owner |
133,333 | $15 | $1,999,995 | 3,606,707 (Indirect) |
View |
| 2020-08-11 Purchase |
2020-08-12 9:00 pm |
Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner |
200,000 | $15 | $3,000,000 | 3,673,374 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-05-28 Other |
2021-06-01 6:44 pm |
N/A N/A |
Checkmate Pharmaceuticals Inc. | CMPI | Krieg Arthur M Chief Scientific Officer |
68,457 | $0 | 1,010,303 (Indirect) |
View |
| 2021-02-26 Exercise |
2021-03-01 4:15 pm |
N/A N/A |
Checkmate Pharmaceuticals Inc. | CMPI | Chaudhary Kleem Chief Business Officer |
2,000 | $2.62 | 105,508 (Direct) |
View |
| 2021-02-26 Exercise |
2021-03-01 4:15 pm |
N/A 2029-11-13 |
Checkmate Pharmaceuticals Inc. | CMPI | Chaudhary Kleem Chief Business Officer |
2,000 | $0 | 105,508 (Direct) |
View |
Ownership(A) |
2021-01-22 4:05 pm |
N/A 2031-01-04 |
Checkmate Pharmaceuticals Inc. | CMPI | Dolski Robert Chief Financial Officer |
0 | $0 | 150,000 (Direct) |
View |
| 2021-01-14 Exercise |
2021-01-15 4:30 pm |
N/A N/A |
Checkmate Pharmaceuticals Inc. | CMPI | Chaudhary Kleem Chief Business Officer |
2,000 | $2.62 | 105,508 (Direct) |
View |
| 2021-01-14 Exercise |
2021-01-15 4:30 pm |
N/A 2029-11-13 |
Checkmate Pharmaceuticals Inc. | CMPI | Chaudhary Kleem Chief Business Officer |
2,000 | $0 | 105,508 (Direct) |
View |
Ownership |
2021-01-14 4:15 pm |
N/A 2031-01-04 |
Checkmate Pharmaceuticals Inc. | CMPI | Dolski Robert Chief Financial Officer |
0 | $0 | 15,000 (Direct) |
View |
| 2020-12-22 Exercise |
2020-12-23 4:15 pm |
N/A N/A |
Checkmate Pharmaceuticals Inc. | CMPI | Chaudhary Kleem Chief Business Officer |
4,000 | $2.62 | 105,508 (Direct) |
View |
| 2020-12-22 Exercise |
2020-12-23 4:15 pm |
N/A 2029-11-13 |
Checkmate Pharmaceuticals Inc. | CMPI | Chaudhary Kleem Chief Business Officer |
4,000 | $0 | 105,508 (Direct) |
View |
| 2020-11-10 Option Award |
2020-11-12 5:20 pm |
N/A 2030-11-09 |
Checkmate Pharmaceuticals Inc. | CMPI | POWELL MICHAEL Director 10% Owner |
30,000 | $0 | 30,000 (Direct) |
View |
| 2020-11-10 Option Award |
2020-11-12 5:16 pm |
N/A 2030-11-09 |
Checkmate Pharmaceuticals Inc. | CMPI | Isacoff Oren Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-11-10 Option Award |
2020-11-12 5:13 pm |
N/A 2030-11-09 |
Checkmate Pharmaceuticals Inc. | CMPI | Colabuono Peter Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-08-11 Conversion |
2020-08-13 4:52 pm |
N/A N/A |
Checkmate Pharmaceuticals Inc. | CMPI | Novo Holdings A/S 10% Owner |
14,157,612 | $0 | 2,170,100 (Direct) |
View |
| 2020-08-11 Conversion |
2020-08-12 9:04 pm |
N/A N/A |
Checkmate Pharmaceuticals Inc. | CMPI | POWELL MICHAEL Sofinnova Venture Partners IX L.P. Sofinnova Management IX L.L.C. HEALY JAMES Director 10% Owner |
28,371,348 | $0 | 3,606,707 (Indirect) |
View |
| 2020-08-11 Conversion |
2020-08-12 9:00 pm |
N/A N/A |
Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner |
28,371,348 | $0 | 3,673,374 (Direct) |
View |
| 2020-08-06 Option Award |
2020-08-10 6:02 pm |
N/A 2030-08-05 |
Checkmate Pharmaceuticals Inc. | CMPI | Brennan Karen Chief Operating Officer |
53,496 | $0 | 53,496 (Direct) |
View |
| 2020-08-06 Option Award |
2020-08-10 6:01 pm |
N/A 2030-08-05 |
Checkmate Pharmaceuticals Inc. | CMPI | Chaudhary Kleem Chief Business Officer |
141,226 | $0 | 141,226 (Direct) |
View |
| 2020-08-06 Option Award |
2020-08-10 6:00 pm |
N/A 2030-08-05 |
Checkmate Pharmaceuticals Inc. | CMPI | Labinger Barry President and CEO |
445,819 | $0 | 445,819 (Direct) |
View |
| 2020-08-06 Option Award |
2020-08-10 6:00 pm |
N/A 2030-08-05 |
Checkmate Pharmaceuticals Inc. | CMPI | Wooldridge James Chief Medical Officer |
150,818 | $0 | 150,818 (Direct) |
View |
Ownership |
2020-08-06 9:16 pm |
N/A N/A |
Checkmate Pharmaceuticals Inc. | CMPI | Krieg Arthur M Chief Scientific Officer |
0 | $0 | 925,968 (Direct) |
View |
Ownership |
2020-08-06 9:12 pm |
N/A N/A |
Checkmate Pharmaceuticals Inc. | CMPI | POWELL MICHAEL Sofinnova Venture Partners IX L.P. Sofinnova Management IX L.L.C. HEALY JAMES Director 10% Owner |
0 | $0 | 3,473,374 (Indirect) |
View |
Ownership |
2020-08-06 9:09 pm |
N/A 2029-11-13 |
Checkmate Pharmaceuticals Inc. | CMPI | Chaudhary Kleem Chief Business Officer |
0 | $0 | 105,508 (Direct) |
View |
Ownership |
2020-08-06 9:08 pm |
N/A 2029-09-05 |
Checkmate Pharmaceuticals Inc. | CMPI | Wooldridge James Chief Medical Officer |
0 | $0 | 95,916 (Direct) |
View |
Ownership |
2020-08-06 9:07 pm |
N/A 2029-06-12 |
Checkmate Pharmaceuticals Inc. | CMPI | Fuhrman Alan Director |
0 | $0 | 22,736 (Direct) |
View |
Ownership |
2020-08-06 9:04 pm |
N/A 2028-12-17 |
Checkmate Pharmaceuticals Inc. | CMPI | Labinger Barry President and CEO |
0 | $0 | 454,913 (Direct) |
View |
Ownership |
2020-08-06 9:04 pm |
2020-03-27 2028-03-27 |
Checkmate Pharmaceuticals Inc. | CMPI | Flaherty Keith T. Director |
0 | $0 | 26,748 (Direct) |
View |
Ownership |
2020-08-06 9:04 pm |
N/A 2027-06-26 |
Checkmate Pharmaceuticals Inc. | CMPI | Brennan Karen Chief Operating Officer |
0 | $0 | 72,153 (Direct) |
View |
Ownership |
2020-08-06 9:03 pm |
N/A N/A |
Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner |
0 | $0 | 3,473,374 (Direct) |
View |
Ownership |
2020-08-06 7:11 pm |
N/A N/A |
Checkmate Pharmaceuticals Inc. | CMPI | Novo Holdings A/S 10% Owner |
0 | $0 | 1,670,100 (Direct) |
View |